EXCLUSIVE CONTENT

By Derek N. Cunningham, OD

Although mild to moderate ptosis is common, affecting about 12% of the population older than 50,^1,2 many eye care specialists are hesitant to engage these patients. Until now, surgery—which is not right for all patients and carries risks including infection and under- or over-correction—was the only effective treatment.³ Upneeq (oxymetazoline hydrochloride 0.1%; Osmotica) represents the only FDA-approved …